Sterling Capital Management LLC Acquires 2,700 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Sterling Capital Management LLC grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 55.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,571 shares of the company’s stock after buying an additional 2,700 shares during the quarter. Sterling Capital Management LLC’s holdings in Henry Schein were worth $524,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HSIC. Invesco Ltd. lifted its stake in shares of Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after purchasing an additional 17,552 shares during the last quarter. FMR LLC lifted its holdings in shares of Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company’s stock worth $242,064,000 after acquiring an additional 217,143 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Henry Schein by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after purchasing an additional 14,876 shares during the period. Lyrical Asset Management LP purchased a new stake in Henry Schein in the 4th quarter worth about $126,655,000. Finally, Clarkston Capital Partners LLC lifted its stake in Henry Schein by 24.8% in the fourth quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company’s stock worth $120,700,000 after purchasing an additional 346,420 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

Shares of HSIC opened at $64.73 on Friday. The company has a 50 day moving average of $70.67 and a two-hundred day moving average of $72.01. The company has a market cap of $7.93 billion, a price-to-earnings ratio of 26.64, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter last year, the business posted $0.66 earnings per share. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the company. StockNews.com lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Finally, Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and an average target price of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.